Therapeutic Area | MeSH |
---|---|
digestive system diseases | D004066 |
Brand Name | Status | Last Update |
---|---|---|
entyvio | Biologic Licensing Application | 2022-10-24 |
entyvio entyvio pen | Biologic Licensing Application | 2024-06-06 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
ulcerative colitis | EFO_0000729 | D003093 | K51 |
crohn disease | EFO_0000384 | D003424 | K50 |
enteritis | — | D004751 | K52.9 |
Code | Description |
---|---|
J3380 | Injection, vedolizumab, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Crohn disease | D003424 | EFO_0000384 | K50 | 2 | 4 | 13 | 13 | 24 | 56 |
Ulcerative colitis | D003093 | EFO_0000729 | K51 | 1 | 3 | 12 | 10 | 23 | 49 |
Colitis | D003092 | EFO_0003872 | K52.9 | — | 3 | 12 | 10 | 15 | 40 |
Ulcer | D014456 | MPATH_579 | — | — | 3 | 12 | 10 | 14 | 39 |
Pouchitis | D019449 | EFO_0003921 | K91.850 | — | — | 1 | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Inflammatory bowel diseases | D015212 | EFO_0003767 | — | — | — | 1 | — | 14 | 15 |
Intestinal diseases | D007410 | — | K63.9 | — | — | 1 | — | 4 | 5 |
Sclerosing cholangitis | D015209 | EFO_0004268 | K83.01 | — | — | 1 | — | — | 1 |
Cholangitis | D002761 | HP_0030151 | K83.0 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Celiac disease | D002446 | EFO_0001060 | K90.0 | — | 1 | — | — | — | 1 |
Enteritis | D004751 | — | K52.9 | — | 1 | — | — | — | 1 |
Gastritis | D005756 | EFO_0000217 | K29.7 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 5 | — | — | — | — | 5 |
Hematopoietic stem cell transplantation | D018380 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Inflammation | D007249 | MP_0001845 | — | — | — | — | — | 1 | 1 |
Drug common name | Vedolizumab |
INN | vedolizumab |
Description | Vedolizumab (humanized mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1743087 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB09033 |
UNII ID | 9RV78Q2002 (ChemIDplus, GSRS) |